Lombard Odier Asset Management (Europe)’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-13,168
Closed -$1.25M 287
2022
Q2
$1.25M Buy
+13,168
New +$1.36M 0.06% 200
2022
Q1
Sell
-8,353
Closed -$1.08M 188
2021
Q4
$1.08M Buy
+8,353
New +$974K 0.05% 150
2021
Q2
Sell
-4,246
Closed -$355K 151
2021
Q1
$355K Buy
+4,246
New +$359K 0.02% 150
2020
Q2
Sell
-6,309
Closed -$397K 203
2020
Q1
$397K Hold
6,309
0.03% 185
2019
Q4
$491K Hold
6,309
0.04% 204
2019
Q3
$462K Hold
6,309
0.04% 202
2019
Q2
$389K Hold
6,309
0.03% 235
2019
Q1
$402K Hold
6,309
0.04% 206
2018
Q4
$322K Hold
6,309
0.03% 239
2018
Q3
$366K Hold
6,309
0.03% 258
2018
Q2
$306K Hold
6,309
0.02% 272
2018
Q1
$293K Sell
6,309
-906
-13% -$39.3K 0.02% 277
2017
Q4
$271K Sell
7,215
-1,470
-17% -$53.9K 0.02% 317
2017
Q3
$316K Hold
8,685
0.02% 309
2017
Q2
$342K Hold
8,685
0.02% 279
2017
Q1
$272K Hold
8,685
0.02% 302
2016
Q4
$271K Hold
8,685
0.1% 270
2016
Q3
$349K Buy
8,685
+591
+7% +$22.3K 0.12% 228
2016
Q2
$269K Buy
+8,094
New +$277K 0.01% 311

Other funds holding EW

Lombard Odier Asset Management (Europe)'s EW Position: Q3 2022 in Review

Lombard Odier Asset Management (Europe) sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 13,168 shares — an estimated $1.25M sold.

Lombard Odier Asset Management (Europe) first reported a position in EW in Q2 2016 and held it in 19 quarters. The position peaked at $1.25M in Q2 2022. 1,247 funds tracked by Wall St. Rank hold EW as of Q3 2022.

  • Lombard Odier Asset Management (Europe) reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (Europe) sold 13,168 Edwards Lifesciences shares in Q3 2022, an estimated $1.25M.
  • Lombard Odier Asset Management (Europe) first reported a position in Edwards Lifesciences in Q2 2016 and held it in 19 quarters.
  • Lombard Odier Asset Management (Europe)'s Edwards Lifesciences position peaked at $1.25M in Q2 2022.
  • 1,247 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q3 2022, filed 14 Nov 2022.